Skip to main content

Table 2 Clinical outcomes according to reactivation status

From: Herpes simplex virus and Cytomegalovirus reactivation among severe ARDS patients under veno-venous ECMO

 Reactivation (n = 67)Non-reactivation (n = 56)p value
Duration of mechanical ventilationa (days)34 (22–52.5)17.5 (9–28)< 0.01
Ventilator-free days at D28a (days)0 (0–0)0 (0–0)0.16
Weaned from ECMO (%)40 (60)27 (48)0.28
Duration of ECMOa (days)15 (10–22.5)9 (5–14)< 0.01
ECMO-free days at D28a (days)0 (0–16)0 (0–17)0.75
ICU mortality (%)34 (51)33 (59)0.47
Hospital mortality (%)35 (52)33 (59)0.58
ICU length of staya (days)29 (19.5–47.5)16 (9–30)< 0.01
Hospital length of staya (days)44 (29–63.5)24 (11–43)< 0.01
Pulmonary fibrosis (%)16 (24)8 (14)0.27
Transfusion of blood productsa11 (7–21.5)10 (6–15)0.05
  1. Data are presented as median and interquartile range or absolute value and percentage
  2. aMedian, 1st–3rd quartile